Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 4
2005 5
2006 1
2007 6
2008 3
2009 1
2010 4
2011 1
2012 6
2013 1
2014 5
2015 1
2016 1
2017 2
2018 5
2019 1
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Maertens JA, et al. Among authors: giladi m. Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10. Lancet. 2016. PMID: 26684607 Clinical Trial.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
Cat-scratch disease-associated arthropathy.
Giladi M, Maman E, Paran D, Bickels J, Comaneshter D, Avidor B, Varon-Graidy M, Ephros M, Wientroub S. Giladi M, et al. Arthritis Rheum. 2005 Nov;52(11):3611-7. doi: 10.1002/art.21411. Arthritis Rheum. 2005. PMID: 16255053 Free article.
The right answer.
Avidor B, Giladi M. Avidor B, et al. Among authors: giladi m. Lancet. 2004 Aug 28-Sep 3;364(9436):758. doi: 10.1016/S0140-6736(04)16932-8. Lancet. 2004. PMID: 15337400 No abstract available.
A cat's scratch or a wolf's bite?
Shmuely H, Chernin G, Giladi M, Zimhony O, Miller EB. Shmuely H, et al. Among authors: giladi m. Lupus. 2020 Oct;29(11):1469-1471. doi: 10.1177/0961203320939632. Epub 2020 Sep 9. Lupus. 2020. PMID: 32903135
Cat-scratch disease: ocular manifestations and treatment outcome.
Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, Amer R, David R, Ben-Arie-Weintrob Y, Bakshi E, Almog Y, Sartani G, Vishnevskia-Dai V, Kramer M, Bar A, Kehat R, Ephros M, Giladi M. Habot-Wilner Z, et al. Among authors: giladi m. Acta Ophthalmol. 2018 Jun;96(4):e524-e532. doi: 10.1111/aos.13684. Epub 2018 Mar 5. Acta Ophthalmol. 2018. PMID: 29504674 Free article.
Asking the right question.
Schattner A, Zimhony O, Avidor B, Giladi M. Schattner A, et al. Among authors: giladi m. Lancet. 2003 May 24;361(9371):1786. doi: 10.1016/S0140-6736(03)13415-0. Lancet. 2003. PMID: 12781538 No abstract available.
Isavuconazole for treatment of rare invasive fungal diseases.
Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G. Cornely OA, et al. Among authors: giladi m. Mycoses. 2018 Aug;61(8):518-533. doi: 10.1111/myc.12778. Mycoses. 2018. PMID: 29611246 Clinical Trial.
57 results